|
|
 |
|
|
Chinese pharmaceutical companies to face the world of "Post Challenge" - pharmaceutical c by sgbvdf asga
|
|
|
Chinese pharmaceutical companies to face the world of "Post Challenge" - pharmaceutical c by SGBVDF ASGA
|
|
| Article Posted: 12/07/2010 |
| Article Views: 69 |
| Articles Written: 2044 - MORE ARTICLES FROM THIS AUTHOR |
| Word Count: 682 |
| Article Votes: 0 |
|
Chinese pharmaceutical companies to face the world of "Post Challenge" - pharmaceutical c |
|
|
|
|
|
Business,Business News,Business Opportunities
|
|
May 6, 2010, China's richest changed hands as a bio-pharmaceutical company?? Hai Purui actual controller Li Li.
This company specializing in the heparin, only a very small global bio-pharmaceutical raw materials breakdown products, but is this sea of blue, this Chinese companies into global share of more than ten years, first created in China The new capital market miracle.
As the world's largest association of life science and biomedical syndication leader of Southern California Medical Association (BIOCOM) chief executive Joseph? Pani Ta (JosephD.Panetta) has not yet never met with China's new richest man But he predicted a similar case in the future may be frequent in China.
"For China's pharmaceutical enterprises," the advantage ", which is the world's pharmaceutical giants in the future will face the biggest challenge." Pani Ta reporter in an exclusive dialogue with no doubts.
BIOCOM, founded in 1995, is the largest regional life science association, the organization has 550 member units, mainly in southern California in San Diego?? Global biomedical coast.
The area of biotechnology industry in the world with a strong competitive advantage in this industry cluster, a world-class research institutions, the source for innovation, venture capital funds provided the Origin and capital incentives, start-ups emerge every day and leading enterprises of the linkage complement each other so that clusters of limitless energy, government resources to promote innovative and interactive elements of the policy of cooperation with a catalyst. The BIOCOM are industrial clusters of the bridge and link.
Conversation, the native-born Americans, mentioned many times China's rapid economic development, while no secret to the Chinese market, he's eager for more business opportunities.
Joseph? Pani Ta is not a businessman, he engaged in the pharmaceutical industry for over 25 years, from the initial group of government officials to now provide professional services business. This statement as to his less scruples.
Example: the patent for pharmaceutical companies long period, he also pointed out that as a high risk investment, investors must ask as many new drugs to make money as long as possible; for Obama's healthcare reform package introduced by the Government , he thought that most Chinese citizens and companies will benefit.
Began in the early morning more than an hour conversation ends, the spring in Beijing, the leaders of the industry a little tired. But his eyes, the distribution of the bio-pharmaceutical industry through the crisis for the passion and dreams, and now, this share fell His gaze is the land of China.
Pharmaceutical market outlook bright Reporter: China is known to have a large number of highly educated professionals, and the market outlook is promising, but at the moment most of China's pharmaceutical companies producing generic drugs remain in the stage, some people pointed out that China's bio-pharmaceutical companies have "the advantage", you agree?
Joseph? Pa Nita: This is a good question, I work trip to China can be a good description of the contents of this issue.
This week, on behalf of BIOCOM partners in Beijing and the signing of three memoranda of cooperation, including direct procurement of drugs and to our technology, and investment cooperation we have established production relations and cooperation.
Illustrates the three co-direction, although Chinese companies enter the competition later, but has a more convenient approach to development. Such as through purchase, then Chinese companies as a market who can immediately grasp the most advanced technology now in production based on this research, I believe can achieve faster, better results.
Other investments as well as through joint ventures, we work with Chinese counterparts, which also helps Chinese companies to train more experienced talent. We also have a large number of production facilities and R & D contracts, which can be taken by China to further cooperation. I am an expert from China Toys Suppliers, usually analyzes all kind of industries situation, such as revolving tie rack , harry bertoia chair.
Related Articles -
revolving tie rack, harry bertoia chair,
|
Rate This Article  |
|
|
|
|
|
Do you Agree or Disagree? Have a Comment? POST IT!
| Reader Opinions |
|
|
|
|
|
|
|
|
|
| Author Login |
|
|
 |
Advertiser Login
ADVERTISE HERE NOW!
Limited Time $60 Offer!
90 Days-1.5 Million Views
|
|
DONNIE LEWIS
I'm an avid consumer of a smoothie a day living, herbs, vitamins and daily dose of exercise. I'm 60...more
|
|
|
|
|
ADRIAN JOELE
I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more
|
|
|
|
|
TIM FAY
After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more
|
|
|
|
|
SUSAN FRIESEN
Located in the lower mainland of B.C., Susan Friesen is a visionary brand strategist, entrepreneur, ...more
|
|
|
|
|
GENE MYERS
Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
|
|
|
|
|
LAURA JEEVES
At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
|
|
|
|
|
STEPHEN BYE
Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through the...more
|
|
|
|
|
STEVE BURGESS
Steve Burgess is a freelance technology writer, a practicing computer forensics specialist as the pr...more
|
|
|
|
|
ALEX BELSEY
I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
|
|
|
|
